AllerGen completes its term as a national Networks of Centres of Excellence (NCE)

AllerGen completes its term as a national Networks of Centres of Excellence (NCE)

After receiving the full 14 years of national Networks of Centres of Excellence (NCE) funding, and an additional two years of support to mobilize knowledge and commercialize research results, AllerGen NCE completes its NCE term today – March 31, 2020.

On this occasion, AllerGen’s Board Chair Dr. Pieter Cullis, President Dr. Diana Royce, and Scientific Director Dr. Judah Denburg are pleased to share messages, and information about AllerGen’s future, with all members and friends of the Network.

Read more